Angela L Jefferson1, Timothy J Hohman1, Dandan Liu2, Shereen Haj-Hassan1, Katherine A Gifford1, Elleena M Benson1, Jeannine S Skinner3, Zengqi Lu2, Jamie Sparling4, Emily C Sumner1, Susan Bell5, Frederick L Ruberg6. 1. Vanderbilt Memory & Alzheimer's Center, Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA. 2. Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA. 3. Vanderbilt-Meharry Alliance, Nashville, TN, USA. 4. Boston University School of Medicine, Boston, MA, USA Newton Wellesley Hospital, Department of Medicine, Newton, MA, USA. 5. Vanderbilt Memory & Alzheimer's Center, Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA Center for Quality Aging, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. 6. Boston University School of Medicine, Boston, MA, USA Section of Cardiovascular Medicine, Boston Medical Center, Boston, MA, USA.
Abstract
BACKGROUND: Cardiovascular disease (CVD) and related risk factors are associated with Alzheimer's disease (AD). This association is less well-defined in normal cognition (NC) or prodromal AD (mild cognitive impairment, MCI). OBJECTIVE: Cross-sectionally and longitudinally relate a vascular risk index to cognitive outcomes among elders free of clinical dementia. METHODS: 3,117 MCI (74 ± 8 years, 56% female) and 6,603 NC participants (72 ± 8 years, 68% female) were drawn from the National Alzheimer's Coordinating Center. A composite measure of vascular risk was defined using the Framingham Stroke Risk Profile (FSRP) score (i.e., age, systolic blood pressure, anti-hypertensive medication, diabetes, cigarette smoking, CVD history, atrial fibrillation). Ordinary linear regressions and generalized linear mixed models related baseline FSRP to cross-sectional and longitudinal cognitive outcomes, separately for NC and MCI, adjusting for age, gender, race, education, and follow-up time (in longitudinal models). RESULTS: In NC participants, increasing FSRP was related to worse baseline global cognition, information processing speed, and sequencing abilities (p-values <0.0001) and a worse longitudinal trajectory on all cognitive measures (p-values <0.0001). In MCI, increasing FSRP correlated with worse longitudinal delayed memory (p = 0.004). In secondary models using an age-excluded FSRP score, associations persisted in NC participants for global cognition, naming, information processing speed, and sequencing abilities. CONCLUSIONS: An adverse vascular risk profile is associated with worse cognitive trajectory, especially global cognition, naming, and information processing speed, among NC elders. Future studies are needed to understand how effective management of CVD and related risk factors can modify cognitive decline to identify the ideal timeframe for primary prevention implementation.
BACKGROUND:Cardiovascular disease (CVD) and related risk factors are associated with Alzheimer's disease (AD). This association is less well-defined in normal cognition (NC) or prodromal AD (mild cognitive impairment, MCI). OBJECTIVE: Cross-sectionally and longitudinally relate a vascular risk index to cognitive outcomes among elders free of clinical dementia. METHODS: 3,117 MCI (74 ± 8 years, 56% female) and 6,603 NC participants (72 ± 8 years, 68% female) were drawn from the National Alzheimer's Coordinating Center. A composite measure of vascular risk was defined using the Framingham Stroke Risk Profile (FSRP) score (i.e., age, systolic blood pressure, anti-hypertensive medication, diabetes, cigarette smoking, CVD history, atrial fibrillation). Ordinary linear regressions and generalized linear mixed models related baseline FSRP to cross-sectional and longitudinal cognitive outcomes, separately for NC and MCI, adjusting for age, gender, race, education, and follow-up time (in longitudinal models). RESULTS: In NC participants, increasing FSRP was related to worse baseline global cognition, information processing speed, and sequencing abilities (p-values <0.0001) and a worse longitudinal trajectory on all cognitive measures (p-values <0.0001). In MCI, increasing FSRP correlated with worse longitudinal delayed memory (p = 0.004). In secondary models using an age-excluded FSRP score, associations persisted in NC participants for global cognition, naming, information processing speed, and sequencing abilities. CONCLUSIONS: An adverse vascular risk profile is associated with worse cognitive trajectory, especially global cognition, naming, and information processing speed, among NC elders. Future studies are needed to understand how effective management of CVD and related risk factors can modify cognitive decline to identify the ideal timeframe for primary prevention implementation.
Authors: Angela L Jefferson; Jayandra J Himali; Alexa S Beiser; Rhoda Au; Joseph M Massaro; Sudha Seshadri; Philimon Gona; Carol J Salton; Charles DeCarli; Christopher J O'Donnell; Emelia J Benjamin; Philip A Wolf; Warren J Manning Journal: Circulation Date: 2010-08-02 Impact factor: 29.690
Authors: D Leys; T Erkinjuntti; D W Desmond; R Schmidt; E Englund; F Pasquier; L Parnetti; J Ghika; R N Kalaria; H Chabriat; P Scheltens; J Bogousslavsky Journal: Alzheimer Dis Assoc Disord Date: 1999 Oct-Dec Impact factor: 2.703
Authors: Katherine J Bangen; Khaled Restom; Thomas T Liu; Amy J Jak; Christina E Wierenga; David P Salmon; Mark W Bondi Journal: Neurobiol Aging Date: 2007-12-21 Impact factor: 4.673
Authors: Juan C Troncoso; Alan B Zonderman; Susan M Resnick; Barbara Crain; Olga Pletnikova; Richard J O'Brien Journal: Ann Neurol Date: 2008-08 Impact factor: 10.422
Authors: Lisa Delano-Wood; Mark W Bondi; Joshua Sacco; Norm Abeles; Amy J Jak; David J Libon; Andrea Bozoki Journal: J Int Neuropsychol Soc Date: 2009-11 Impact factor: 2.892
Authors: Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris Journal: Alzheimer Dis Assoc Disord Date: 2009 Apr-Jun Impact factor: 2.703
Authors: Isabelle Pelcher; Christian Puzo; Yorghos Tripodis; Hugo J Aparicio; Eric G Steinberg; Alyssa Phelps; Brett Martin; Joseph N Palmisano; Elizabeth Vassey; Cutter Lindbergh; Ann C McKee; Thor D Stein; Ronald J Killiany; Rhoda Au; Neil W Kowall; Robert A Stern; Jesse Mez; Michael L Alosco Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Timothy J Hohman; Lauren R Samuels; Dandan Liu; Katherine A Gifford; Shubhabrata Mukherjee; Elleena M Benson; Ty Abel; Frederick L Ruberg; Angela L Jefferson Journal: Neurobiol Aging Date: 2015-06-06 Impact factor: 4.673
Authors: Warren D Taylor; Yi Deng; Brian D Boyd; Manus J Donahue; Kimberly Albert; Maureen McHugo; Jason A Gandelman; Bennett A Landman Journal: Brain Imaging Behav Date: 2020-02 Impact factor: 3.978
Authors: Katie E Osborn; Jonathan M Alverio; Logan Dumitrescu; Kimberly R Pechman; Katherine A Gifford; Timothy J Hohman; Kaj Blennow; Henrik Zetterberg; Angela L Jefferson Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Ramon Casanova; Santiago Saldana; Michael W Lutz; Brenda L Plassman; Maragatha Kuchibhatla; Kathleen M Hayden Journal: J Gerontol B Psychol Sci Soc Sci Date: 2020-03-09 Impact factor: 4.077